Valneva SE (VALN) Change in Working Capital (2021 - 2026)
Valneva SE (VALN) posted Change in Working Capital of $20.2 million for Q1 2026, up 16442.61% sequentially from -$123388.6 in Q4 2025, and up 308.94% YoY from $4.9 million in Q1 2025.
Analysis
Valneva SE (VALN) Change in Working Capital (2021 - 2026) Analysis & Trends
Valneva SE has reported Change in Working Capital for 6 years, with the latest figure at $20.2 million in Q1 2026.
- Quarterly Change in Working Capital rose 308.94% year-over-year to $20.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.6 million (up 134.03% YoY) and the FY2025 annual result came in at $1.7 million, down 86.12% from the prior year.
- Change in Working Capital climbed to $20.2 million in Q1 2026 per VALN's latest filing, from -$123388.6 in the prior quarter.
- Over five years, Change in Working Capital peaked at $46.5 billion in Q3 2023 and troughed at -$46.6 billion in Q2 2023.
- A 5-year average of $10.8 million and a median of -$123388.6 in 2025 frame the typical range for Change in Working Capital.
- The widest YoY moves for Change in Working Capital: up 41843.2% in 2023, down 29580.84% in 2023.
- Over 5 years, Change in Working Capital stood at -$51.6 million in 2022, then surged by 598.31% to $257.1 million in 2023, then slumped by 80.68% to $49.7 million in 2024, then plunged by 100.25% to -$123388.6 in 2025, then soared by 16442.61% to $20.2 million in 2026.
- According to Business Quant data, Change in Working Capital over the past three periods registered $20.2 million, -$123388.6, and $10.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Working Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Valneva SE | 578.54 Mn | 437.28 Mn | 1.86 Mn | 2.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.38 Mn |
| Mar 31, 2026 | 3,512.24 |
| Dec 31, 2025 | 181,590.79 |
| Sep 30, 2025 | 831,198.17 |
| Jun 30, 2025 | 53,202.11 |
| Mar 31, 2025 | 430,220.74 |
| Dec 31, 2024 | -524,680.34 |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | -633,209.89 |
| Mar 31, 2024 | -574,685.37 |
| Dec 31, 2023 | 747,778.24 |
| Sep 30, 2023 | -303.91 Mn |
| Jun 30, 2023 | 304.10 Mn |
| Mar 31, 2023 | -288,728.95 |
| Dec 31, 2022 | 8.42 Mn |
| Sep 30, 2022 | -63.65 Mn |
| Jun 30, 2022 | -93.99 Mn |
| Mar 31, 2022 | -5.35 Mn |
| Dec 31, 2021 | 63.08 Mn |
| Sep 30, 2021 | -4.87 Mn |